Publications by authors named "Barbara Pizzo"

Claim this Profile
P
Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer.
Daniel T Milton, Gregory J Riely, Christopher G Azzoli, Jorge E Gomez, Robert T Heelan, Barbara Pizzo

Cancer· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer.
Christopher G Azzoli, Lee M Krug, Vincent A Miller, Naiyer A Rizvi, Mark G Kris, Barbara Pizzo

J Thorac Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors.
Christopher G Azzoli, Lee M Krug, Jorge Gomez, Vincent A Miller, Mark G Kris, Barbara Pizzo

Clin Cancer Res· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors.
Matthew G Fury, David B Solit, Yungpo Bernard Su, Neal Rosen, F M Sirotnak, Barbara A Pizzo

Cancer Chemother Pharmacol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma.
Lee M Krug, Vincent A Miller, Jyoti Patel, John Crapanzano, Christopher G Azzoli, Barbara Pizzo

Cancer· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial.
Lee M Krug, John P Crapanzano, Christopher G Azzoli, Vincent A Miller, Naiyer Rizvi, Barbara Pizzo

Cancer· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical management of patients with non-small-cell lung cancer treated with gefitinib.
Neelam T Shah, Mark G Kris, William Pao, Leslie B Tyson, Barbara M Pizzo

J Clin Oncol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin.
Lee M Krug, Govind Ragupathi, Chandra Hood, Mark G Kris, Vincent A Miller, Barbara Pizzo

Clin Cancer Res· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New directions in oncology nursing care: focus on gefitinib in patients with lung cancer.
Barbara Pizzo

Clin J Oncol Nurs· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.
Vincent A Miller, Mark G Kris, Neelam Shah, Jyoti Patel, Christopher Azzoli, Barbara Pizzo

J Clin Oncol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin.
Lee M Krug, Govind Ragupathi, Kenneth K Ng, Chandra Hood, Harold J Jennings, Barbara Pizzo

Clin Cancer Res· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot trial of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib plus carboplatin and paclitaxel in patients with stage IIIB or IV non-small-cell lung cancer.
Vincent A Miller, David H Johnson, Lee M Krug, Barbara Pizzo, Leslie Tyson

J Clin Oncol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.
Lee M Krug, Christopher G Azzoli, Mark G Kris, Vincent A Miller, Nushmia Z Khokhar, Barbara Pizzo

Clin Cancer Res· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis